44 (59%) patients received metformin, 43 (57%) received an SGLT2 inhibitor, and 37 (49%) received insulin concurrently with GLP-1 RA
GLP-1 receptor agonists available in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus) - Ozempic and Rybelsus for diabetes, Wegovy for weight management Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) - Victoza for diabetes, Saxenda for weight management Lixisenatide (Lyxumia) Exenatide (Byetta, Bydureon) - though usage has declined in recent years These medications are administered either as once-daily, once-weekly, or twice-daily subcutaneous injections, with one oral formulation (semaglutide) also available
Four in ten (40%) admit they have switched off phone alarms and forgotten, while the same proportion (40%) say they have misplaced or failed to update their notes
Epub 2025 Sep 16
Each capsule contains a standardized BPC-157 amount with research-grade purity verified by HPLC